• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[免疫功能低下宿主的结核病临床特征]

[The clinical features for tuberculosis in compromised hosts].

作者信息

Yamagishi Fumio

机构信息

Department of Respiratory Diseases, National Hospital Organization Chiba-East National Hospital, Chiba, Japan.

出版信息

Kekkaku. 2006 Oct;81(10):631-8.

PMID:17094586
Abstract

We investigated the clinical features and measures for tuberculosis with diabetes mellitus, AIDS, gastrectomy, malignant tumor, or receiving anti-tumor necrosis factor-alpha. In these days, tuberculosis patients with diabetes mellitus are increasing. Their tuberculosis is often found in advanced cases and the periods of symptomatics are short. In short, in tuberculosis with diabetes mellitus, the progress of tuberculosis is fast. Japanese patients of tuberculosis with AIDS are frequent in mid-life and increasing. Extra-pulmonary tuberculosis including disseminated tuberculosis is frequent with patients of AIDS. The prognosis of them is improved with the spread of HAART treatment. The most frequent occasion for gastrectomy is gastric cancer and the prognosis is good. Many of them are thin and malnutrition. The prognosis of tuberculosis with malignant tumor is bad, especially with lung cancer and malignant lymphoma. People receiving infliximab, an antitumor necrosis factor-alpha, are frequent to have onset of tuberculosis. Particularly, extra-pulmonary tuberculosis, including disseminated tuberculosis are often. Tuberculin reaction before receiving infliximab are weak. No one, receiving chemoprophylaxis, has onset of tuberculosis. When the rate of chemoprophylaxis increases, the number of tuberculosis patients decreases. Immunocompromised hosts need to be examined periodical or extraordinary when they had symptoms of tuberculosis to discover the onset of tuberculosis. To prevent the onset of tuberculosis, patients who previously infected tuberculosis should receive active chemoprophylaxis regardless of their age.

摘要

我们调查了合并糖尿病、艾滋病、胃切除术、恶性肿瘤或接受抗肿瘤坏死因子-α治疗的结核病患者的临床特征及应对措施。近年来,合并糖尿病的结核病患者数量不断增加。他们的结核病往往在病情晚期才被发现,且症状期较短。简而言之,合并糖尿病的结核病患者病情进展迅速。日本合并艾滋病的结核病患者多见于中年且数量不断增加。艾滋病患者中肺外结核(包括播散性结核)较为常见。随着高效抗逆转录病毒治疗(HAART)的普及,他们的预后有所改善。胃切除术最常见的原因是胃癌,且预后良好。其中许多患者体型消瘦且营养不良。合并恶性肿瘤的结核病患者预后较差,尤其是合并肺癌和恶性淋巴瘤的患者。接受抗肿瘤坏死因子-α药物英夫利昔单抗治疗的人经常会发生结核病。特别是肺外结核,包括播散性结核较为常见。接受英夫利昔单抗治疗前结核菌素反应较弱。接受化学预防的人无人发生结核病。当化学预防的比例增加时,结核病患者数量会减少。免疫功能低下的宿主在出现结核病症状时需要定期或格外进行检查,以便发现结核病的发病情况。为预防结核病的发生,既往感染过结核的患者无论年龄大小均应接受积极的化学预防。

相似文献

1
[The clinical features for tuberculosis in compromised hosts].[免疫功能低下宿主的结核病临床特征]
Kekkaku. 2006 Oct;81(10):631-8.
2
[Tuberculosis in compromised hosts].[免疫功能低下宿主中的结核病]
Kekkaku. 2003 Nov;78(11):717-22.
3
[Measures for tuberculosis in compromised hosts--mainly on chemoprophylaxis].[免疫功能低下宿主结核病的防治措施——主要关于化学预防]
Kekkaku. 2003 Oct;78(10):661-7.
4
[Prevention of development of pulmonary tuberculosis in compromised host].[免疫功能低下宿主肺结核病的预防]
Kekkaku. 2001 Feb;76(2):77-81.
5
[Medical risk factors of tuberculosis and countermeasures].[结核病的医学危险因素及应对措施]
Kekkaku. 2002 Dec;77(12):799-804.
6
[Management of pulmonary tuberculosis patients complicated with diabetes mellitus before diagnosis as pulmonary tuberculosis and feasibility of chemoprophylaxis].[肺结核合并糖尿病患者在肺结核诊断前的管理及化学预防的可行性]
Kekkaku. 2000 Aug;75(8):505-9.
7
[Pulmonary tuberculosis in the compromised host at the point of clinical view].
Kekkaku. 1993 Sep;68(9):605-10.
8
[Application and problems of quantiFERON TB-2G for tuberculosis control programs--(2) clinical use of quantiFERON TB-2G].[结核感染T细胞检测(QuantiFERON TB-2G)在结核病防控项目中的应用及问题——(2)结核感染T细胞检测(QuantiFERON TB-2G)的临床应用]
Kekkaku. 2007 Jan;82(1):61-6.
9
[Preventive measures against tuberculosis in working facilities and companies].[工作场所和公司内的结核病预防措施]
Kekkaku. 2007 Mar;82(3):201-16.
10
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.